Following the detection of ‘hPL’ in breast cancer cell lines by multiple antibodies, we next used mAb-1 and mAb-12 to determine whether immunoreactive hPL is detectable in primary breast tumors and normal breast tissue. Here, LGALS1 is linked to breast cancer.